Key points are not available for this paper at this time.
Abstract Backround Level one evidence reported poorer outcomes among patients taking dietary supplements after breast cancer (BC) diagnosis. Methods We evaluated dietary supplement behaviours among adult BC patients via questionnaire. Sociodemographic data, supplement use, attitudes, and healthcare provider (HCP) advice were analysed. Results Of 185 participants, 45% were regular supplement users following diagnosis. Regular supplement use was associated with higher education level ( p = 0.05). The majority perceived supplements to be safe. Over half reported not receiving advice from HCPs. Conclusion In summary, supplement use is prevalent among BC patients. Development of guidelines in relation to safe use of dietary supplements after cancer diagnosis is crucial.
O’Donovan et al. (Sat,) studied this question.